UK markets close in 2 hours 59 minutes

Onconetix, Inc. (ONCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1410-0.0032 (-2.22%)
At close: 04:00PM EDT
0.1461 +0.01 (+3.62%)
Pre-market: 08:00AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1442
Open0.1400
Bid0.1459 x 100
Ask0.1480 x 100
Day's range0.1400 - 0.1500
52-week range0.1000 - 1.2100
Volume719,193
Avg. volume4,455,322
Market cap3.148M
Beta (5Y monthly)3.73
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

    CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology, today announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors. “We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chair